Opioid Safety: A Community Pharmacy Intervention to Prevent Opioid Adverse Drug Events

Combatting the opioid epidemic is a top national priority and identification of effective public health strategies is of primary importance.1 Since 1999, the amount of prescription opioids sold in the U.S. nearly quadrupled.2 Reducing adverse drug events (ADEs), particularly those attributed to opioids, is also a national priority.3

This Special Innovation Project, implemented in the AQIN area of New York State, the District of Columbia, and South Carolina, is tailored to enhance usual care pharmacist counseling with opioid-specific content, such as communicating explicitly that opioid use exposes the patient to dependence and addiction. Specific pharmacist-patient interventions will include assessment of patient risk for overdose and naloxone offer, if appropriate, and laxative and stool softener recommendations to prevent opioid induced constipation. Specific pharmacist-prescriber interventions will include contacting the prescriber for benzodiazepine de-escalation when used concurrently with opioids, if appropriate and informing prescribers when morphine milligram equivalent (MME) daily dose exceeds ≥ 90 MME.4 The intervention will be implemented within the pharmacist dispensing workflow for all patients presenting with opioid prescriptions in volunteer recruited pharmacies. The desired outcomes include an increase in the number of naloxone prescriptions dispensed by participating pharmacies and a decrease in the incidence of opioid-related emergency department visits for Medicare fee-for-service beneficiaries.

Continuing education training created by the University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Office of Continuing Pharmacy Education and advanced pharmacist counseling materials are also provided for all participating pharmacists. Recruitment of pharmacies for this project is closed, however pharmacists can still obtain the training and receive ACPE© credits and use the counseling materials via the links below.

Continuing Education

The continuing education activities are:

  • "Pharmacist's Response to the Opioid Epidemic: Advanced, Opioid Specific Counseling", providing 1.5 ACPE© credits.
  • "Naloxone Pharmacy Continuing Education Program", providing 2 ACPE© credits.

They can be accessed here.

THE COURSE CONTENT INCLUDES EXAMPLES AND REFERENCES to NEW YORK STATE LAWS, REGULATIONS AND RESOURCES. PLEASE REFER TO YOUR SPECIFIC STATE LAWS AND REGULATIONS WHEN AND WHERE APPLICABLE.

DC Law: https://code.dccouncil.us/dc/council/laws/21-186.html

SC Law: https://www.scstatehouse.gov/code/t44c130.php

Pharmacists who work in New York State, the District of Columbia and South Carolina can waive the fee for the CE by using the appropriate code based on the state you work in: aqin2018NY, aqin2018DC, aqin2018SC.

Advanced Opioid Patient Counseling Materials

Opioid Stewardship: Opioid Counseling checklist – A tool intended to help remind pharmacists about opioid-related counseling points as needed when using the conversation starter. Click here to view the tool.

Conversation starter: Opioid dispensing, education, and management for pharmacists – A tool designed to aid the pharmacist in starting the conversation about opioids with patients and care givers. Click here to view the tool.

PEG Scale Assessing Pain Intensity and Interference (Pain, Enjoyment, General Activity) – A tool to assess a patient’s pain, enjoyment, and ability to accomplish their general activities. Click here to view the tool.

Pain Zone Tool – A tool to help the patient rate their comfort level and what to do depending on their responses. Click here to view the tool.

For more information contact:

New York State: Tanya Vadala, Pharm.D.

District of Columbia: Jennifer Thomas, Pharm.D.

South Carolina: Cheryl Anderson, BS, RPh.

  • 1  Schuchat A, Houry D, Guy GP. New data on opioid use and prescribing in the US.JAMA,2017 Jul 6; doi:10.1001/jama.2017.8913
  • 2  CDC. Wide-ranging online data for epidemiologic research (WONDER). Atlanta, GA: CDC, National Center for Health Statistics; 2016. Available at http://wonder.cdc.gov
  • 3 U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion. (2014). National Action Plan for Adverse Drug Event Prevention. Washington, DC
  • 4  Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain —United States, 2016. MMWR Recomm Rep 2016;65(No. RR-1):1–49. DOI: http://dx.doi.org/10.15585/mmwr.rr6501e1

Initiatives

Care Coordination
Care Coordination DC
Resources
Care Coordination NY
Overview
Beneficiaries and Families
Healthcare Professionals
Other Website Resources
Tools and Resources
Past Success
Upcoming Events
Past Events
Blog
Contact Us
Care Coordination SC
Cardiovascular Health
Cardiovascular Health (DC)
Cardiovascular Health (NY)
Cardiovascular Health (SC)
Community Based Sepsis
Educational Webinar Programs
Sepsis in the News
Tools and Resources
Diabetes Self-Management
EDC Foot Care Campaign
Diabetes Self-Management Education (DC)
Diabetes Self-Management Education (NY)
Diabetes Self-Management Education (SC)
Drug Safety
Anticoagulation Safety
Hypoglycemia Avoidance
Opioid Safety
Opioid Safety (DC)
Opioid Safety in Community Pharmacy
Drug Safety (DC)
Drug Safety (NY)
Drug Safety (SC)
Hospital Safety
Hospital Safety (DC)
Hospital Safety (NY)
Hospital Safety (SC)
Immunization
Immunization (DC)
Immunization (NY)
Immunization (SC)
SC Immunization Coalition Materials
Español
Nursing Home Quality
Nursing Home Quality (NY)
QAPI Self-Assessment
Casper Data
Eliminating Inappropriate Antipsychotic Medication Use
Clinical Quality Measures (QM)
Composite Measure Score
NHQCC Collaborative I Kick-Off
NHQCC Collaborative I Outcomes Congress
QI/QAPI
Using a System's Approach to Quality & Performance Improvement
Nursing Home Quality Care Collaborative (NHQCC) Learning
Engaging Staff in Individualized Care
QAPI Self-Assessment and Related Resources
QAPI In Action
Quality Improvement (QI) Resources
Quality Improvement Strategies
Steps to QAPI
Elements for Framing QAPI in Nursing Homes
Clinical Topics
Medication Use Tools & Resources
Pressure Ulcer Clinical Tools & Resources
Restraint Clinical Tools & Resources
Falls with Major Injuries
Health Care Acquired Conditions
Eliminating Long Term Care Re-Admissions Tools & Resources
Resources
Consumers
Nursing Home Quality (DC)
Nursing Home Quality (SC)
ACE e-Newsletter
Clinical Topics
Organizational Change
Presentations and Handouts
QI/QAPI
Upcoming Events
Outpatient Antibiotic Stewardship
Core Element One: Commitment
Core Element Two: Action for Policy and Practice
Core Element Three: Tracking and Reporting
Core Element Four: Education and Expertise
Technology-Enhanced Care
Meaningful Use of HIT (DC)
Meaningful Use of HIT (NY)
Meaningful Use of HIT (SC)
Transforming End of Life
Quality Payment Program
CMS Webinars & Programs
QPP Support for Large Practices
QPP Support for Small Practices
Request Technical Assistance
QPP Education
QPP General Information
Quality Measures
Improvement Activities (IA)
Promoting Interoperability (PI)
Cost
Alternative Payment Models (APMs)

Contact Us

New York
Anne Myrka, Director, Drug Safety
518-320-3591
anne.myrka@area-i.hcqis.org

District of Columbia
Jennifer Thomas, PharmD
Medication Safety, Immunizations, & 
Antibiotic Stewardship 
Atlantic Quality Innovation Network – District of Columbia 
Qlarant 
7067 Columbia Gateway Drive, Suite 290 
Columbia, Maryland 21046 
Tel: 410-872-9698 
(800) 876-3362, Ext. 11565 
Secure Fax (516) 233-3355
thomasj@qlarant.com

South Carolina
Cheryl Anderson, Medication Safety Pharmacist
803-212-7560
Cheryl.Anderson@area-I.hcqis.org